Yanyan Peng
About Yanyan Peng
Yanyan Peng is a Principal Scientist at BeiGene and a Senior Medical Advisor at AstraZeneca in Shanghai, China, with extensive experience in preclinical drug discovery and oncology biomarker diagnosis.
Company
Yanyan Peng is currently employed at BeiGene as a Principal Scientist in Shanghai City, China. BeiGene is a global biotechnology company focused on developing innovative and affordable oncology therapeutics. Peng took on this role starting in April 2022. Alongside this, Peng also works as a Senior Medical Advisor at AstraZeneca, located in Shanghai.
Title
Yanyan Peng holds the title of Principal Scientist at BeiGene and Senior Medical Advisor at AstraZeneca in Shanghai. These roles involve significant responsibilities in drug discovery, oncology biomarker diagnosis, and advising on medical strategies.
Education and Expertise
Yanyan Peng holds a Doctor of Philosophy (Ph.D.) in Biochemistry and Molecular Biology from Peking University (2010-2015). Prior to that, Peng earned a Bachelor's Degree in Biology/Biological Sciences from Northeast Normal University (2006-2010). Peng has cultivated deep expertise in preclinical drug discovery, including work on both small molecules and antibodies. Peng is also experienced in oncology biomarker diagnosis as part of the role at AstraZeneca.
Background
Yanyan Peng's career has been rooted in the pharmaceutical industry. From 2015 to 2017, Peng worked as Scientist II at Eli Lilly China in Shanghai. Following that, Peng served as Senior Scientist at Laekna Therapeutics from 2017 to 2019. Peng’s extensive background also includes significant experience in pharmaceutical R&D and medical advisory roles.